Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.1 USD | +2.45% | -4.21% | -13.85% |
02:00pm | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
Mar. 08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.85% | 1.36B | |
-2.67% | 102B | |
+2.02% | 96.29B | |
+1.86% | 22.18B | |
-15.33% | 21.2B | |
-8.77% | 18.31B | |
-38.74% | 17.38B | |
-14.17% | 16.36B | |
+5.55% | 13.97B | |
+32.97% | 12.17B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Akero Therapeutics' Q4 Loss Widens; Cash Expected to Fund Operations Into 2026